Literature DB >> 10548512

Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.

T Sato1, Y Sawaji, N Matsui, H Sato, M Seiki, Y Mori, A Ito.   

Abstract

Expression of membrane type-1 matrix metalloproteinase (MT1-MMP) is closely correlated with tumor invasiveness. We investigated the effect of hyperthermia on the production of MT1-MMP in human fibrosarcoma HT-1080 cells. Heat shock at 42 degrees C suppressed the production and gene expression of MT1-MMP in HT-1080 cells. Heat shock-induced suppression of MT1-MMP production resulted in the inhibition of progelatinase A (proMMP-2) activation and the increased release of tissue inhibitor of metalloproteinases 2 from cell surface. In addition, in vitro tumor invasion assay in a Matrigel model indicated that heat shock inhibited the invasive activity of HT-1080 cells. These results suggest that heat shock preferentially suppresses the production of MT1-MMP and thereby inhibits proMMP-2 activation, events which subsequently inhibit tumor invasion. Therefore, heat shock shows an anti-invasive effect along with the known mechanism of inhibiting tumor growth. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548512     DOI: 10.1006/bbrc.1999.1637

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Heat shock-mediated transient increase in intracellular 3',5'-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation.

Authors:  Y Sawaji; T Sato; M Seiki; A Ito
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

Authors:  Kosei Nakajima; Takashi Yanagawa; Hideomi Watanabe; Kenji Takagishi
Journal:  Oncol Rep       Date:  2012-10-01       Impact factor: 3.906

3.  Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro.

Authors:  Y Sawaji; T Sato; A Takeuchi; M Hirata; A Ito
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

4.  Anti-Metastatic Benefits Produced by Hyperthermia and a CCL3 Derivative.

Authors:  Liqiu Ma; Ryosuke Kambe; Tomoko Tsuchiya; Shiro Kanegasaki; Akihisa Takahashi
Journal:  Cancers (Basel)       Date:  2019-11-11       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.